Vutrisiran injection cut risk of death and adverse cardiovascular events by at least 28%, company says
Info Econômico – Seu Portal de Notícias Econômicas
Fonte US biotech Alnylam hails positive trial results for heart disease drug
Vutrisiran injection cut risk of death and adverse cardiovascular events by at least 28%, company says
Info Econômico – Seu Portal de Notícias Econômicas
Fonte US biotech Alnylam hails positive trial results for heart disease drug